Sunflower is developing an AI-powered telemedicine platform focused on addiction treatment, addressing a significant unmet need with over 18,750 patients currently on waitlists for therapy or medication. The company launched Sunflower Sober, the first AI-driven support tool for individuals in recovery, which reached 100 million monthly active users within six months and now generates approximately $1.5 million in annual recurring subscription revenue. This rapid growth positions Sunflower as one of the fastest-expanding digital communities in sobriety, outpacing traditional programs like Alcoholics Anonymous.
The company is expanding beyond its app to build comprehensive clinical services, aiming to meet the needs of underserved populations and serve Medicaid, which allocates over $30 billion annually toward substance use disorder care. Founded by Koby, who previously led growth at Rupa, the team includes medical professionals from institutions such as the Mayo Clinic, Choose Your Horizon, and Charlie Health. Sunflower combines scalable technology with clinical expertise to deliver accessible, evidence-based addiction care.